Literature DB >> 27623868

Epigenetic Control of Reprogramming and Transdifferentiation by Histone Modifications.

Hua Qin1, Andong Zhao1, Cuiping Zhang2, Xiaobing Fu3.   

Abstract

Somatic cells can be reprogrammed to pluripotent stem cells or transdifferentiate to another lineage cell type. Much efforts have been made to unravel the epigenetic mechanisms underlying the cell fate conversion. Histone modifications as the major epigenetic regulator are implicated in various aspects of reprogramming and transdifferentiation. Here, we discuss the roles of histone modifications on reprogramming and transdifferentiation and hopefully provide new insights into induction and promotion of the cell fate conversion by modulating histone modifications.

Keywords:  Cell fate conversion; Epigenetic; Histone modifications; Reprogramming; Somatic cells; Transdifferentiation; iPSCs

Mesh:

Substances:

Year:  2016        PMID: 27623868     DOI: 10.1007/s12015-016-9682-4

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  89 in total

1.  Conversion of mouse fibroblasts into cardiomyocyte-like cells using small molecule treatments.

Authors:  Gyuman Park; Byung Sun Yoon; Yoon Sik Kim; Seung-Cheol Choi; Jai-Hee Moon; Suhyun Kwon; Jihye Hwang; Wonjin Yun; Jong-Ho Kim; Chi-Yeon Park; Do-Sun Lim; Yang In Kim; Chil Hwan Oh; Seungkwon You
Journal:  Biomaterials       Date:  2015-04-11       Impact factor: 12.479

2.  PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming.

Authors:  Zhuo Zhang; Amanda Jones; Chiao-Wang Sun; Chao Li; Chia-Wei Chang; Heui-Yun Joo; Qian Dai; Matthew R Mysliwiec; Li-Chen Wu; Yahong Guo; Wei Yang; Kaimao Liu; Kevin M Pawlik; Hediye Erdjument-Bromage; Paul Tempst; Youngsook Lee; Jinrong Min; Tim M Townes; Hengbin Wang
Journal:  Stem Cells       Date:  2011-02       Impact factor: 6.277

3.  H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.

Authors:  Jiekai Chen; He Liu; Jing Liu; Jing Qi; Bei Wei; Jiaqi Yang; Hanquan Liang; You Chen; Jing Chen; Yaran Wu; Lin Guo; Jieying Zhu; Xiangjie Zhao; Tianran Peng; Yixin Zhang; Shen Chen; Xuejia Li; Dongwei Li; Tao Wang; Duanqing Pei
Journal:  Nat Genet       Date:  2012-12-02       Impact factor: 38.330

Review 4.  Transdifferentiation of Fibroblasts by Defined Factors.

Authors:  Zhiliang Zhao; Mengyao Xu; Meng Wu; Xiaocheng Tian; Cuiping Zhang; Xiaobing Fu
Journal:  Cell Reprogram       Date:  2015-06       Impact factor: 1.987

5.  Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination.

Authors:  Wei Zhao; Qingtian Li; Stephen Ayers; Yifeng Gu; Zhong Shi; Qingyuan Zhu; Yidong Chen; Helen Y Wang; Rong-Fu Wang
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

6.  Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation.

Authors:  Maria Jesus Perugorria; Caroline L Wilson; Mujdat Zeybel; Meagan Walsh; Shilu Amin; Stuart Robinson; Steven A White; Alastair D Burt; Fiona Oakley; Hidekazu Tsukamoto; Derek A Mann; Jelena Mann
Journal:  Hepatology       Date:  2012-09       Impact factor: 17.425

7.  Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells.

Authors:  Matthias Stadtfeld; Effie Apostolou; Francesco Ferrari; Jiho Choi; Ryan M Walsh; Taiping Chen; Steen S K Ooi; Sang Yong Kim; Timothy H Bestor; Toshi Shioda; Peter J Park; Konrad Hochedlinger
Journal:  Nat Genet       Date:  2012-03-04       Impact factor: 38.330

Review 8.  Pioneer transcription factors in cell reprogramming.

Authors:  Makiko Iwafuchi-Doi; Kenneth S Zaret
Journal:  Genes Dev       Date:  2014-12-15       Impact factor: 11.361

9.  MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.

Authors:  Jelena Mann; David C K Chu; Aidan Maxwell; Fiona Oakley; Nian-Ling Zhu; Hidekazu Tsukamoto; Derek A Mann
Journal:  Gastroenterology       Date:  2009-10-17       Impact factor: 22.682

10.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

View more
  6 in total

1.  Clonally related diffuse large B-cell lymphoma and interdigitating dendritic cell sarcoma sharing MYC translocation.

Authors:  Yotaro Ochi; Nobuhiro Hiramoto; Tetsuichi Yoshizato; Yuichiro Ono; June Takeda; Yusuke Shiozawa; Kenichi Yoshida; Nobuyuki Kakiuchi; Yuichi Shiraishi; Hiroko Tanaka; Kenichi Chiba; Yasuhiro Kazuma; Sumie Tabata; Noboru Yonetani; Keiichiro Uehara; Daisuke Yamashita; Yukihiro Imai; Koji Nagafuji; Mitsunori Yamakawa; Satoru Miyano; Akifumi Takaori-Kondo; Seishi Ogawa; Takayuki Ishikawa
Journal:  Haematologica       Date:  2018-09-20       Impact factor: 9.941

2.  High Yap and Mll1 promote a persistent regenerative cell state induced by Notch signaling and loss of p53.

Authors:  Julian Heuberger; Johanna Grinat; Frauke Kosel; Lichao Liu; Séverine Kunz; Ramon Oliveira Vidal; Marlen Keil; Johannes Haybaeck; Sylvie Robine; Daniel Louvard; Christian Regenbrecht; Anje Sporbert; Sascha Sauer; Björn von Eyss; Michael Sigal; Walter Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

Review 3.  The essentiality of non-coding RNAs in cell reprogramming.

Authors:  Joachim Luginbühl; Divya Mundackal Sivaraman; Jay W Shin
Journal:  Noncoding RNA Res       Date:  2017-04-13

4.  Valproic acid prevents glucocorticoid‑induced osteonecrosis of the femoral head of rats.

Authors:  Ding Zhou; Yi-Xuan Chen; Jun-Hui Yin; Shi-Cong Tao; Shang-Chun Guo; Zhan-Ying Wei; Yong Feng; Chang-Qing Zhang
Journal:  Int J Mol Med       Date:  2018-03-06       Impact factor: 4.101

5.  Enhancement of Chromatin and Epigenetic Reprogramming in Porcine SCNT Embryos-Progresses and Perspectives.

Authors:  Werner Giehl Glanzner; Mariana Priotto de Macedo; Karina Gutierrez; Vilceu Bordignon
Journal:  Front Cell Dev Biol       Date:  2022-07-11

Review 6.  Cell Reprogramming to Model Huntington's Disease: A Comprehensive Review.

Authors:  Ruth Monk; Bronwen Connor
Journal:  Cells       Date:  2021-06-22       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.